CI - NYSE

Cigna Corporation

CI·NYSE

$270.73

-1.3%

HealthcareMedical - Healthcare Plans

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$71.62B

EPS22.3000

P/E Ratio12.14

Earnings Date07/30/2026

157.92B

Assets

3Y+10.0%

5Y+2.0%

10Y+166.0%

116.05B

Total Liabilities

3Y+17.0%

5Y+10.0%

10Y+155.0%

41.87B

Total Equity

3Y-7.0%

5Y-17.0%

10Y+204.0%

Cigna Corporation Funding & Solvency Profile

CI · NYSE

Current Assets

Cash & Cash Equivalents7.68B

Net Receivables28.77B

Inventory7.34B

Other Current Assets4.03B

Total Current Assets48 B

Non-Current Assets

Property, Plant & Equipment3.65B

Goodwill & Intangible Assets73.48B

Long-Term Investments18.47B

Other Non-Current Assets14.50B

Total Non-Current Assets37 B

Total Assets

157.92B

Financial Health Analysis

Current Ratio

0.85x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

2.77x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-8528000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

30% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Cigna Corporation Balance Sheet

CI • NYSE

Cigna Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	7.7B	7.6B	7.8B	5.9B	5.1B	10.2B	4.6B	3.9B	3B	3.2B	2B	1.4B	2.8B	3B	4.7B	1.6B	924M	1.3B	2B	1.4B
Short-Term Investments	0.0	665M	925M	905M	920M	1.3B	937M	2B	2.1B	691M	381M	163M	631M	154M	225M	174M	493M	236M	12.8B	12.8B
Cash & Short-Term Investments	7.7B	8.2B	8.7B	6.8B	6B	11.5B	5.6B	5.9B	3.2B	3.9B	2.3B	1.6B	3.4B	3.1B	4.9B	1.8B	1.4B	1.6B	14.7B	14.2B
Net Receivables	28.8B	24.1B	17.5B	17B	14.6B	12B	10.4B	10.2B	2.9B	3B	3.6B	2.8B	0.0	0.0	7.6B	1.3B	1.4B	1.4B	1.4B	9.5B
Accounts Receivables	28.8B	24.1B	17.5B	17B	14.6B	12B	10.4B	10.2B	2.9B	3B	3.6B	2.8B	0.0	0.0	7.6B	1.3B	1.4B	1.4B	1.4B	9.5B
Inventory	7.3B	6.7B	5.6B	4.8B	3.7B	3.2B	2.7B	2.8B	228M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	4B	9.9B	5.5B	1.5B	11.8B	1.1B	11.2B	1.5B	1.1B	6.5B	7.9B	8B	0.0	0.0	38.8B	37.3B	36.5B	33.2B	14.2B	16.3B
Total Current Assets	47.8B	48.9B	37.4B	30.1B	36.1B	27.8B	29.8B	20.4B	9.3B	13.4B	13.8B	12.4B	2.8B	3B	45.1B	40.4B	39.3B	36.2B	37.7B	40B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	3.7B	828M	877M	1.3B	1.7B	1.7B	1.8B	1.3B	756M	767M	800M	778M	829M	573M	1B	912M	862M	804M	625M	632M
Goodwill	44.9B	44.4B	44.3B	45.8B	45.8B	44.6B	44.6B	44.5B	6.2B	6B	6B	6B	6B	6B	3.2B	3.1B	2.9B	0.0	1.8B	1.7B
Intangible Assets	28.6B	32.2B	33.7B	35.3B	36.9B	38.2B	39.8B	42.3B	1.2B	1.2B	1.3B	1.4B	2.9B	2.8B	1.8B	1.2B	0.0	4.4B	0.0	0.0
Goodwill & Intangible Assets	73.5B	76.6B	77.9B	81.2B	82.7B	82.8B	84.4B	86.8B	7.3B	7.2B	7.3B	7.4B	9B	8.8B	4.9B	4.4B	2.9B	4.4B	1.8B	1.7B
Long-Term Investments	18.5B	15.1B	18B	16.2B	18.4B	23.2B	21.5B	26.9B	26.5B	25.4B	23.5B	24.2B	0.0	0.0	16.5B	15B	14B	12.1B	12.8B	12.8B
Other Non-Current Assets	14.5B	14.4B	18.6B	15.1B	16B	19.9B	18.3B	17.8B	17.9B	12.6B	11.7B	11.1B	41.8B	-9.4B	-16.5B	-15B	-14B	-12.1B	-12.8B	-12.8B
Total Non-Current Assets	110.1B	107B	115.4B	113.8B	118.8B	127.7B	125.9B	132.8B	52.4B	45.9B	43.3B	43.5B	51.5B	9.4B	6B	5.3B	3.7B	5.2B	2.4B	2.4B
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83M	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	157.9B	155.9B	152.8B	143.9B	154.9B	155.5B	155.8B	153.2B	61.8B	59.4B	57.1B	55.9B	54.3B	53.7B	51B	45.7B	43B	41.4B	40.1B	42.4B
LIABILITIES
CURRENT LIABILITIES
Total Payables	10.7B	37.8B	28.4B	24.8B	22B	18.8B	15.5B	15.1B	489M	8.9B	8.8B	8.4B	7.5B	8.5B	1.3B	0.0	0.0	0.0	0.0	0.0
Accounts Payable	10.7B	37.8B	28.4B	24.8B	22B	18.8B	15.5B	15.1B	489M	5.5B	4.7B	5.3B	0.0	0.0	1.3B	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	6.5B	7.8B	7.9B	7.2B	8.4B	5.9B	7.1B	3.7B	2.5B	128M	115M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Short Term Debt	592M	3B	2.7B	3B	2.5B	3.4B	5.5B	2.8B	231M	250M	100M	100M	0.0	0.0	104M	552M	104M	301M	3M	382M
Capital Lease Obligations (Current)	0.0	43M	42M	147M	182M	170M	193M	117M	9M	26M	49M	47M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	45.1B	10.7B	9.7B	5.4B	11.7B	5.3B	13B	6.8B	6.6B	0.0	885M	929M	0.0	0.0	-1.4B	-552M	-104M	-301M	-3M	-382M
Total Current Liabilities	56.3B	58B	48.7B	41.2B	43.6B	36B	40.1B	31.9B	11B	8.3B	5.8B	6.5B	0.0	0.0	104M	552M	104M	301M	3M	382M
NON-CURRENT LIABILITIES
Long Term Debt	30.9B	28.9B	28.1B	28B	31.1B	29.5B	31.8B	39.5B	5.2B	4.7B	5B	5B	5B	5B	5B	2.3B	2.4B	2.1B	1.8B	1.3B
Deferred Tax Liabilities (Non-Current)	7.1B	7B	7.2B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	21.7B	20.7B	22.4B	29.5B	32.6B	39B	37.9B	40.7B	31.8B	32.6B	34.1B	33.5B	38.6B	-5B	-5B	-2.3B	-2.4B	-2.1B	-1.8B	-1.3B
Total Non-Current Liabilities	59.7B	56.7B	57.7B	57.9B	64.1B	69B	70.3B	80.3B	37B	37.3B	39.2B	38.5B	43.7B	5B	5B	2.3B	2.4B	2.1B	1.8B	1.3B
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6B	36.2B	35B	35.4B	33.5B	36.4B
Capital Lease Obligations	68M	84M	108M	559M	646M	697M	526M	149M	9M	20M	32M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	116B	114.6B	106.4B	99B	107.7B	105.1B	110.4B	112.2B	48B	45.6B	45B	45B	43.7B	43.9B	42.7B	39B	37.6B	37.8B	35.3B	38.1B
SHAREHOLDERS' EQUITY
Treasury Stock	-35.1B	-31.4B	-24.2B	-21.8B	-14.2B	-6.4B	-2.2B	-104M	-4B	-1.7B	-1.8B	-1.4B	-6B	-5.3B	-5.3B	-5.2B	-5.2B	-5.3B	-5B	-4.2B
Common Stock	4M	4M	4M	4M	4M	4M	4M	4M	74M	74M	74M	74M	92M	92M	92M	88M	88M	88M	88M	40M
Additional Paid-In Capital	31.8B	31.3B	30.7B	30.2B	29.6B	29B	28.3B	27.8B	2.9B	2.9B	2.9B	2.8B	3.4B	3.3B	3.2B	2.5B	2.5B	2.5B	2.5B	2.5B
Retained Earnings	47.9B	43.5B	41.7B	37.9B	32.6B	28.6B	20.2B	15.1B	15.8B	13.9B	12.1B	10.3B	13.7B	12.3B	11.1B	9.9B	8.6B	7.4B	7.1B	6.2B
Accumulated Other Comprehensive Income/Loss	-2.8B	-2.3B	-1.9B	-1.4B	-884M	-861M	-941M	-1.7B	-1.1B	-1.4B	-1.3B	-936M	-520M	-671M	-793M	-614M	-618M	-1.1B	51M	-169M
Total Stockholders' Equity	41.7B	41B	46.2B	44.9B	47.1B	50.3B	45.3B	41B	13.7B	13.7B	12B	10.8B	10.6B	9.8B	8.3B	6.6B	5.4B	3.6B	4.7B	4.3B
Total Equity	41.9B	41.2B	46.4B	45B	47.2B	50.4B	45.4B	41.1B	13.8B	13.8B	12.1B	10.9B	10.7B	9.9B	8.3B	6.7B	5.4B	3.6B	4.7B	4.3B
Minority Interest	161M	210M	128M	79M	72M	65M	41M	44M	49M	62M	78M	105M	110M	114M	0.0	18M	12M	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	157.9B	155.9B	152.8B	143.9B	154.9B	155.5B	155.8B	153.2B	61.8B	59.4B	57.1B	55.9B	54.3B	53.7B	51B	45.7B	43B	41.4B	40.1B	42.4B
Total Investments	18.5B	15.8B	18.9B	17.1B	19.3B	24.5B	22.4B	29B	28.6B	26.1B	23.9B	24.3B	0.0	0.0	22.5B	15.2B	14.5B	12.4B	17.6B	25.6B
Total Debt	31.5B	32B	30.9B	31.6B	34.3B	33.6B	38B	42.5B	5.4B	5B	5.2B	5.1B	5B	0.0	5.1B	2.8B	2.5B	2.4B	1.8B	1.7B
Net Debt	23.8B	24.4B	23.1B	25.6B	29.2B	23.4B	33.4B	38.6B	2.5B	1.8B	3.2B	3.7B	2.2B	0.0	404M	1.2B	1.6B	1B	-177M	284M
Shares Outstanding	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816	267,125,816

SEC Filings

CI - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 22, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 13, 2026	April 22, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 03, 2026	February 25, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 27, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 05, 2026	February 05, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 18, 2025	October 22, 2025	2025	View Filing

Showing 1 to 10 of 179 filings

Related Guides

Blog Categories

Continue your CI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.